• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

真实世界证据可提高决策质量。

Real-world evidence enhances decision making.

机构信息

University of Arizona College of Pharmacy, Tucson.

出版信息

J Manag Care Spec Pharm. 2020 Dec;26(12):1612-1614. doi: 10.18553/jmcp.2020.26.12.1612a.

DOI:10.18553/jmcp.2020.26.12.1612a
PMID:33252000
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10390944/
Abstract

No funding supported the writing of this commentary. The author has nothing to disclose.

摘要

本评论文章的撰写未获得任何资金支持。作者无利益披露。

相似文献

1
Real-world evidence enhances decision making.真实世界证据可提高决策质量。
J Manag Care Spec Pharm. 2020 Dec;26(12):1612-1614. doi: 10.18553/jmcp.2020.26.12.1612a.
2
Can the learning health care system be educated with observational data?学习型医疗保健系统能否通过观察性数据进行培育？
JAMA. 2014 Jul;312(2):129-30. doi: 10.1001/jama.2014.4364.
3
When Can We Rely on Real-World Evidence to Evaluate New Medical Treatments?何时我们可以依靠真实世界证据来评估新的医疗疗法？
Clin Pharmacol Ther. 2022 Jan;111(1):30-34. doi: 10.1002/cpt.2253. Epub 2021 May 19.
4
Information technology innovation: the power and perils of big data.信息技术创新：大数据的力量与风险
Br J Anaesth. 2015 Sep;115(3):339-42. doi: 10.1093/bja/aev154. Epub 2015 Jun 1.
5
Is Real-World Evidence Used in P&T Monographs and Therapeutic Class Reviews?是否在药品评审和支付管理专论及治疗类别审查中使用真实世界证据？
J Manag Care Spec Pharm. 2020 Dec;26(12):1604-1611. doi: 10.18553/jmcp.2020.26.12.1604.
6
Using Health System Data for Improvement Science: Getting Started.利用卫生系统数据开展改进科学：入门指南。
AACN Adv Crit Care. 2018 Fall;29(3):348-353. doi: 10.4037/aacnacc2018653.
7
The '70% claim': what is the evidence base?“70%说法”：证据基础是什么？
Ann Clin Biochem. 2011 Nov;48(Pt 6):487-8. doi: 10.1258/acb.2011.011177.
8
Can Digital Health Enable Higher Quality Real-World Evidence-Based Decisions?数字健康能否助力做出更高质量的基于真实世界证据的决策？
Clin Pharmacol Ther. 2019 Jul;106(1):45-46. doi: 10.1002/cpt.1440. Epub 2019 Apr 23.
9
Taking a byte out of big data.从大数据中抽取一部分。
J Am Dent Assoc. 2015 Nov;146(11):793-4. doi: 10.1016/j.adaj.2015.09.002.
10
[All evidence is real world evidence.].所有证据均为真实世界证据。
Recenti Prog Med. 2019 Apr;110(4):165-167. doi: 10.1701/3154.31342.

本文引用的文献

1
Awareness, Knowledge, and Utility of RCT Data vs RWE: Results From a Survey of US Cardiologists: Real-world Evidence in Clinical Decision Making.随机对照试验数据与真实世界证据的认知、知识及效用：美国心脏病专家调查结果：临床决策中的真实世界证据
Clin Med Insights Cardiol. 2020 Sep 2;14:1179546820953410. doi: 10.1177/1179546820953410. eCollection 2020.
2
Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing-Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative.提高透明度以建立对假设检验的真实世界二次数据研究的信任——原因、内容和方法：来自真实世界证据透明度倡议的建议和路线图。
Value Health. 2020 Sep;23(9):1128-1136. doi: 10.1016/j.jval.2020.04.002.
3
Susan G. Komen Big Data for Breast Cancer Initiative: How Patient Advocacy Organizations Can Facilitate Using Big Data to Improve Patient Outcomes.苏珊·G·科门乳腺癌大数据倡议：患者权益倡导组织如何助力利用大数据改善患者治疗效果。
JCO Precis Oncol. 2019 Sep 12;3. doi: 10.1200/PO.19.00184. eCollection 2019.
4
Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS).利用真实世界数据为决策提供信息：多发性硬化症合作伙伴推动技术与健康解决方案（MS PATHS）。
Front Neurol. 2020 Aug 7;11:632. doi: 10.3389/fneur.2020.00632. eCollection 2020.
5
Weighing the Benefits and Risks of Proliferating Observational Treatment Assessments: Observational Cacophony, Randomized Harmony.权衡不断增加的观察性治疗评估的益处与风险：观察性杂音与随机和谐
JAMA. 2020 Aug 18;324(7):625-626. doi: 10.1001/jama.2020.13319.
6
Treatment Patterns and Costs in Biologic DMARD-Naive Patients with Rheumatoid Arthritis Initiating Etanercept or Adalimumab with or Without Methotrexate.生物制剂初治类风湿关节炎患者接受依那西普或阿达木单抗联合或不联合甲氨蝶呤治疗的模式和费用。
J Manag Care Spec Pharm. 2020 Mar;26(3):285-294. doi: 10.18553/jmcp.2020.26.3.285.
7
Application of a Graphical Depiction of Longitudinal Study Designs to Managed Care Pharmacy Research.图形化表述纵向研究设计在管理式医疗药学研究中的应用。
J Manag Care Spec Pharm. 2020 Mar;26(3):268-274. doi: 10.18553/jmcp.2020.26.3.268.
8
Adherence and Persistence with DPP-4 Inhibitors Versus Pioglitazone in Type 2 Diabetes Patients with Chronic Kidney Disease: A Retrospective Claims Database Analysis.在患有慢性肾脏病的 2 型糖尿病患者中，与吡格列酮相比，DPP-4 抑制剂的依从性和持久性：一项回顾性索赔数据库分析。
J Manag Care Spec Pharm. 2020 Jan;26(1):67-75. doi: 10.18553/jmcp.2020.26.1.67.
9
Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States.美国终末期肾病伴房颤患者应用阿哌沙班的结局。
Circulation. 2018 Oct 9;138(15):1519-1529. doi: 10.1161/CIRCULATIONAHA.118.035418.
10
Real-World Evidence: Useful in the Real World of US Payer Decision Making? How? When? And What Studies?真实世界证据：在美国医保支付方决策的现实世界中有用吗？如何有用？何时有用？以及哪些研究有用？
Value Health. 2018 Mar;21(3):326-333. doi: 10.1016/j.jval.2017.08.3013. Epub 2017 Oct 18.